Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
03/16/2010 | CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
03/16/2010 | CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein |
03/11/2010 | WO2010028349A2 Fluorochromes for organelle tracing and multi-color imaging |
03/11/2010 | WO2010027779A2 Pesticidal compositions |
03/11/2010 | WO2010027097A1 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors |
03/11/2010 | WO2009139886A3 Targeting an hiv-1 nef-host cell kinase complex |
03/11/2010 | WO2009050734A9 An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines |
03/11/2010 | US20100063027 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity |
03/11/2010 | US20100062429 Fluorochromes for organelle tracing and multi-color imaging |
03/11/2010 | US20100061928 Labelled analogues of halobenzamides as radiopharmaceuticals |
03/11/2010 | CA2736281A1 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors |
03/11/2010 | CA2734273A1 Fluorochromes for organelle tracing and multi-color imaging |
03/11/2010 | CA2733659A1 Sulfoxime pesticidal compounds and methods related thereto |
03/09/2010 | US7674909 Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
03/09/2010 | US7674899 Dimeric azacyclic compounds and their use |
03/09/2010 | US7674807 N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid; 3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid; effect against harmful insects without giving phytotoxicity on cultured plants |
03/09/2010 | US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
03/09/2010 | US7674791 Triazolopyrazines and methods of making and using the same |
03/09/2010 | US7674530 Luminescent polymer |
03/09/2010 | CA2482346C Substituted phenylacetamides and their use as glucokinase activators |
03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
03/09/2010 | CA2306313C Dipeptide nitriles |
03/04/2010 | WO2010025370A2 Preparation of ranolazine |
03/04/2010 | WO2009145591A3 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
03/04/2010 | WO2009145590A3 Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof |
03/04/2010 | US20100056786 Method for Producing Alkylanilides from Halobenzene Derivatives |
03/04/2010 | US20100056546 Sulfonylurea inhibitors of atp-sensitive potassium channels |
03/04/2010 | US20100056534 Pesticidal compositions |
03/04/2010 | US20100056530 Glucokinase activators |
03/04/2010 | US20100051106 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
03/03/2010 | EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
03/03/2010 | CN101663283A 喹喔啉化合物及其用途 Quinoxaline compounds and their uses |
03/03/2010 | CN101663282A Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity |
03/02/2010 | US7671201 Phenyl substituted cyclic derivatives |
03/02/2010 | US7671198 Process for preparing intermediates to 5-HT4 receptor agonist compounds |
03/02/2010 | US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide |
03/02/2010 | US7671058 N-(3,4-disubstituted phenyl) salicylamide derivatives |
03/02/2010 | US7671055 Insecticidal 3-(dihaloalkenyl) phenyl derivatives |
02/25/2010 | WO2010021878A1 Cold menthol receptor antagonists |
02/25/2010 | WO2010021149A1 Spiro compound capable of inhibiting acid secretion |
02/25/2010 | WO2010020548A1 Glyt1 receptor antagonists |
02/25/2010 | WO2009110985A3 Amide compounds, compositions and uses thereof |
02/25/2010 | US20100048901 Novel curcumin derivative |
02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
02/25/2010 | US20100048857 Thermoplastic polyphenoxyquinoxaline and method of preparing the same |
02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
02/25/2010 | US20100048589 Cold Menthol Receptor Antagonists |
02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
02/25/2010 | US20100048586 Multifunctional bioactive compounds |
02/25/2010 | US20100048550 Selective tr-beta 1 agonist |
02/25/2010 | US20100048540 Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors |
02/25/2010 | US20100047483 Birefringent film, laminated film, and image display device |
02/25/2010 | US20100047178 Perylenequinone derivatives and uses thereof |
02/24/2010 | EP2155893A2 Novel nitroreductase enzymatic substrates |
02/24/2010 | EP2155892A2 Novel peptidase substrates |
02/24/2010 | EP2155736A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
02/24/2010 | EP2155697A1 Substituted piperazines |
02/24/2010 | EP2155696A2 Piperazine salts as d3/d2 antagonists |
02/24/2010 | EP1971580B1 Piperazine compounds with a herbicidal action |
02/24/2010 | EP1000999B1 Compounds for organic el devices and organic el devices |
02/23/2010 | CA2345146C Cyanophenyl derivative |
02/23/2010 | CA2335461C Calcium channel blockers |
02/18/2010 | WO2010019911A2 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
02/18/2010 | WO2010018067A1 Method for preparation of piperazindione derivates |
02/18/2010 | US20100041665 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
02/18/2010 | US20100041653 Composition and methods for the design and development of metallo-enzyme inhibitors |
02/18/2010 | US20100041573 Amine reaction compounds comprising one or more active ingredient |
02/18/2010 | US20100039024 New Heterocyclic bridged biphenyls |
02/18/2010 | CA2734305A1 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
02/17/2010 | EP2153819A2 Compositions containing therapeutically active components having enhanced solubility |
02/17/2010 | EP2091942B1 Substituted pyrazinone derivatives for use as a medicine |
02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
02/17/2010 | CN101648917A Mequindox metabolic product and preparation method and application thereof |
02/17/2010 | CN101648916A Method for preparing 4-substituted-2-piperazine carboxylic acid |
02/17/2010 | CN101648915A Method for synthesizing and separating piperazine-2-carboxylic acid |
02/16/2010 | US7662961 5,5'-{Oxybis[ethane-2,1-diyl(methylimino)]}bis[1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-4-trifluoromethylsulfonylpyrazole]; pest control of insects, arachnids and helminths |
02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
02/16/2010 | US7662816 Cognition activators; neurodegenerative disorders; Alzheimer's disease |
02/16/2010 | US7662487 Stability; efficiency; hole injection or hole transporting material |
02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
02/16/2010 | CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound |
02/16/2010 | CA2385081C Carboxylic acid compound and a medicament comprising it |
02/11/2010 | WO2010017060A1 Urea derivatives as antibacterial agents |
02/11/2010 | WO2010015524A1 Method for stereoselective synthesis of bicyclic heterocyclene |
02/11/2010 | WO2009093141A3 Novel inhibitors of mycobacterium complex cytochrome p450 cyp121 |
02/11/2010 | US20100036126 Stereoselective synthesis of (s)-1-methyl-3-phenylpiperazine |
02/11/2010 | US20100035879 N-sulfonylcarboximidamide apoptosis promoters |
02/11/2010 | US20100035279 Fluorescent Substrates for Monoamine Transporters as Optical False Neurotransmitters |
02/11/2010 | CA2732045A1 Urea derivatives as antibacterial agents |
02/11/2010 | CA2731895A1 Process for the stereoselective preparation of bicyclic heterocycles |
02/10/2010 | EP2151439A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same |
02/10/2010 | EP2151436A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
02/10/2010 | EP2150550A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
02/09/2010 | US7659396 N-(2,4,6-triisopropylphenylsulfonyl)-3-amidino(or guanidino)phenyl-alanine 4-ethoxycarbonylpiperazide; urokinase inhibitors; reacting a 3-cyanophenylalanine with a quaternary ammonium hydroxide and reacting the product with a phenylsulfonyl halide; industrial scale; simplification; cost efficiency |
02/09/2010 | US7659395 Analgesics; antidiabetic agents;anticancer agents;psychological disorders; schizophrenia; neurodegenerative diseases |
02/09/2010 | US7659270 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
02/09/2010 | CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
02/09/2010 | CA2268403C Anthranilic acid derivatives as multi drug resistance modulators |